Skip to content

Author

Seyyedehfatemeh Ghalibafan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Severe Dupilumab-Associated Ocular Surface Disease: Multicenter Experience and Management Considerations.

Severe DAOSD may be underrecognized, as mild early symptoms can delay referral and allow progression to advanced, vision-threatening complications and early ophthalmologic evaluation and timely referral are essential to prevent irreversible ocular surface damage and vision loss.

Allison Y. Kufta, Syeda Zainab Kazmi, Seyyedehfatemeh Ghalibafan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.